Results
1 -
2 of
2A phase II study of extended dose temozolomide and thalidomide in previously treated patients with metastatic melanoma, Journal of Cancer Research and Clinical Oncology Comparison of the cytotoxicity in vitro of temozolomide and dacarbazine, prodrugs of 3-methyl-(triazen-1-yl)imidazole-4-carboxamide, Cancer Chemotherapy and Pharmacology